Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Fertilization01:24

In Vitro Fertilization

1.5K
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
1.5K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

471
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
471
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

685
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
685

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case of early pregnancy pulmonary embolism following mifepristone administration: a call for increased pharmacovigilance and research.

Blood transfusion = Trasfusione del sangue·2026
Same author

Pulmonary embolism epidemiology: trends, risk factors, comorbidities, and clinical implications.

European heart journal·2026
Same author

From Endometriosis to Endometriosis-Associated Ovarian Cancer: Molecular Mechanisms, Risk Stratification and Clinical Implications.

Cancers·2026
Same author

Identifying Thromboprophylaxis and Aspirin Use in Pregnancy: Predictors and Maternal Outcomes-the Italian MoMs Study.

Thrombosis and haemostasis·2025
Same author

Clinical and Genetic Heterogeneity of Factor XI Deficiency: Insights from a Southern Italian Cohort.

International journal of molecular sciences·2025
Same author

Management of Pregnancy, Delivery, and Postpartum in Italian Carriers and Women With Haemophilia A and B.

Haemophilia : the official journal of the World Federation of Hemophilia·2025

Related Experiment Video

Updated: Apr 14, 2026

Minimally Invasive Embryo Transfer and Embryo Vitrification at the Optimal Embryo Stage in Rabbit Model
07:02

Minimally Invasive Embryo Transfer and Embryo Vitrification at the Optimal Embryo Stage in Rabbit Model

Published on: May 16, 2019

13.6K

Assisted reproductive technologies and thrombosis.

Elvira Grandone1, Michela Villani1

  • 1Atherosclerosis and Thrombosis Unit, IRCCS Casa Sollievo della Sofferenza, S. Giovanni Rotondo, Foggia, Italy.

Thrombosis Research
|April 24, 2015
PubMed
Summary

This article discusses thrombotic risk and antithrombotic prophylaxis use during and after assisted reproductive technologies (ART). It highlights gaps in understanding the incidence, causes, and management of these risks, especially concerning thrombophilias.

Keywords:
Assisted reproductive technologies (ART)PregnancyThromboprophylaxisThrombosis

More Related Videos

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

1.3K
Human Blastocyst Biopsy and Vitrification
10:59

Human Blastocyst Biopsy and Vitrification

Published on: July 26, 2019

24.2K

Related Experiment Videos

Last Updated: Apr 14, 2026

Minimally Invasive Embryo Transfer and Embryo Vitrification at the Optimal Embryo Stage in Rabbit Model
07:02

Minimally Invasive Embryo Transfer and Embryo Vitrification at the Optimal Embryo Stage in Rabbit Model

Published on: May 16, 2019

13.6K
Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

1.3K
Human Blastocyst Biopsy and Vitrification
10:59

Human Blastocyst Biopsy and Vitrification

Published on: July 26, 2019

24.2K

Area of Science:

  • Reproductive Medicine
  • Thrombosis Research
  • Obstetrics

Background:

  • Assisted reproductive technologies (ART) are associated with an increased risk of thrombotic events.
  • The precise incidence, pathogenesis, and risk factors for thrombosis during and after ART pregnancies are not fully understood.
  • Existing data on thrombophilia screening and the efficacy of antithrombotic prophylaxis in this population are limited.

Purpose of the Study:

  • To review and discuss the current understanding of thrombotic risk associated with ART.
  • To examine the role of thrombophilias in ART-related thrombosis.
  • To evaluate the efficacy and indications for antithrombotic prophylaxis in ART pregnancies.

Main Methods:

  • Literature review and synthesis of existing data.
  • Discussion of known and potential risk factors for thrombosis.
  • Analysis of the role of thrombophilias and thromboprophylaxis.

Main Results:

  • Significant knowledge gaps exist regarding the incidence, pathogenesis, and magnitude of thrombotic risk in ART.
  • The contribution of thrombophilias to ART-related thrombotic events requires further elucidation.
  • Evidence supporting the routine use of antithrombotic prophylaxis in all ART patients is insufficient.

Conclusions:

  • Further research is needed to clarify thrombotic risk stratification and management strategies in ART.
  • Personalized approaches to thromboprophylaxis, considering individual risk factors, may be warranted.
  • A comprehensive understanding of thrombotic complications is crucial for optimizing ART outcomes.